These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7630318)
1. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor. Tateishi K; Kitayama N; Matsuoka Y; Funakoshi A Life Sci; 1995; 57(9):889-95. PubMed ID: 7630318 [TBL] [Abstract][Full Text] [Related]
2. Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors. Yasuda D; Iguchi H; Funakoshi A; Wakasugi H; Sekiya K; Misawa T; Tateishi K; Bloom SR; Nawata H Horm Metab Res; 1993 Nov; 25(11):593-5. PubMed ID: 8288164 [TBL] [Abstract][Full Text] [Related]
4. Production and secretion of chromogranin A and pancreastatin by the human pancreatic carcinoma cell line QGP-1N on stimulation with carbachol. Kitayama N; Tateishi K; Funakoshi A; Kono A; Matsuoka Y Regul Pept; 1994 Aug; 52(3):195-203. PubMed ID: 7800852 [TBL] [Abstract][Full Text] [Related]
5. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024 [TBL] [Abstract][Full Text] [Related]
6. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Syversen U; Mignon M; Bonfils S; Kristensen A; Waldum HL Acta Oncol; 1993; 32(2):161-5. PubMed ID: 8323758 [TBL] [Abstract][Full Text] [Related]
7. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats. Myers NC; Andrews GA; Chard-Bergstrom C Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968 [TBL] [Abstract][Full Text] [Related]
8. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366 [TBL] [Abstract][Full Text] [Related]
9. Pancreastatin producing cell line from human pancreatic islet cell tumor. Funakoshi A; Tateishi K; Tsuru M; Jimi A; Wakasugi H; Ikeda Y; Kono A Biochem Biophys Res Commun; 1990 Apr; 168(2):741-6. PubMed ID: 2159299 [TBL] [Abstract][Full Text] [Related]
10. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency. Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646 [TBL] [Abstract][Full Text] [Related]
11. Regulation of pancreastatin release from a human pancreatic carcinoid cell line in vitro. Jeng YJ; Townsend CM; Nagasawa S; Chuo S; Kern K; Yanaihara N; Ferrar RS; Hill FL; Thompson JC; Greeley GH Endocrinology; 1991 Jan; 128(1):220-5. PubMed ID: 1702700 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329 [TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory functions of chromogranin A-derived peptide pancreastatin. Ioannidis M; Mahata SK; van den Bogaart G Peptides; 2022 Dec; 158():170893. PubMed ID: 36244579 [TBL] [Abstract][Full Text] [Related]
15. Prohormone convertase-1 is essential for conversion of chromogranin A to pancreastatin. Udupi V; Lee HM; Kurosky A; Greeley GH Regul Pept; 1999 Sep; 83(2-3):123-7. PubMed ID: 10511466 [TBL] [Abstract][Full Text] [Related]
16. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma. Stridsberg M; Husebye ES Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129 [TBL] [Abstract][Full Text] [Related]
17. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection. Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994 [TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of prohormone convertase-1 by a phorbol ester. Udupi V; Townsend CM; Gomez G; Zhang T; Greeley GH Biochem Biophys Res Commun; 1995 Dec; 217(2):495-500. PubMed ID: 7503727 [TBL] [Abstract][Full Text] [Related]
20. A phylogenetic survey of pancreastatin and chromogranin immunoreactivity in chromaffin (TH-, DBH-, and PNMT-immunoreactive) cells of the adrenal organ of vertebrates. Reinecke M; Maake C Gen Comp Endocrinol; 1993 May; 90(2):251-65. PubMed ID: 8100544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]